These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38640832)

  • 1. The utility of the irritability scale in Huntington's disease patients with evidence of irritability or aggression.
    En-Hua Wang J; Simon NG; Brownstein MJ; Maibach HT; Maibach J; Anderson KE
    Parkinsonism Relat Disord; 2024 Jun; 123():106087. PubMed ID: 38640832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing Mental Health Difficulties of Persons With Huntington's Disease: Does Informant Presence Make a Difference?
    Gunn S; Maltby J; Dale M
    J Neuropsychiatry Clin Neurosci; 2020; 32(3):244-251. PubMed ID: 32102601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irritability in a Prospective Cohort of Huntington's Disease Mutation Carriers.
    Bouwens JA; van Duijn E; van der Mast RC; Roos RA; Giltay EJ
    J Neuropsychiatry Clin Neurosci; 2015; 27(3):206-12. PubMed ID: 26067436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irritability in Huntington's Disease.
    Karagas NE; Rocha NP; Stimming EF
    J Huntingtons Dis; 2020; 9(2):107-113. PubMed ID: 32417789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irritability in Huntington's disease.
    Reedeker N; Bouwens JA; Giltay EJ; Le Mair SE; Roos RA; van der Mast RC; van Duijn E
    Psychiatry Res; 2012 Dec; 200(2-3):813-8. PubMed ID: 22537721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY).
    van Duijn E; Craufurd D; Hubers AA; Giltay EJ; Bonelli R; Rickards H; Anderson KE; van Walsem MR; van der Mast RC; Orth M; Landwehrmeyer GB;
    J Neurol Neurosurg Psychiatry; 2014 Dec; 85(12):1411-8. PubMed ID: 24828898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of irritability in Huntington's disease: A scoping review.
    Simpson J; Dale M; Theed R; Gunn S; Zarotti N; Eccles FJR
    Cortex; 2019 Nov; 120():353-374. PubMed ID: 31401402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of self-report and caregiver assessment of depression, apathy, and irritability in Huntington's disease.
    Chatterjee A; Anderson KE; Moskowitz CB; Hauser WA; Marder KS
    J Neuropsychiatry Clin Neurosci; 2005; 17(3):378-83. PubMed ID: 16179661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Vasopressin 1a Receptor Antagonist SRX246 Reduces Aggressive Behavior in Huntington's Disease.
    Maibach HT; Brownstein MJ; Hersch SM; Anderson KE; Itzkowitz DE; Damiano EM; Simon NG
    J Pers Med; 2022 Sep; 12(10):. PubMed ID: 36294700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Irritability Questionnaire: a new scale for the measurement of irritability.
    Craig KJ; Hietanen H; Markova IS; Berrios GE
    Psychiatry Res; 2008 Jun; 159(3):367-75. PubMed ID: 18374422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations.
    Mestre TA; van Duijn E; Davis AM; Bachoud-Lévi AC; Busse M; Anderson KE; Ferreira JJ; Mahlknecht P; Tumas V; Sampaio C; Goetz CG; Cubo E; Stebbins GT; Martinez-Martin P;
    Mov Disord; 2016 Oct; 31(10):1466-1478. PubMed ID: 27296904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irritability in pre-clinical Huntington's disease.
    Klöppel S; Stonnington CM; Petrovic P; Mobbs D; Tüscher O; Craufurd D; Tabrizi SJ; Frackowiak RS
    Neuropsychologia; 2010 Jan; 48(2):549-57. PubMed ID: 19878688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor analysis of behavioural symptoms in Huntington's disease.
    Rickards H; De Souza J; van Walsem M; van Duijn E; Simpson SA; Squitieri F; Landwehrmeyer B;
    J Neurol Neurosurg Psychiatry; 2011 Apr; 82(4):411-2. PubMed ID: 20392980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical Trial.
    Brownstein MJ; Simon NG; Long JD; Yankey J; Maibach HT; Cudkowicz M; Coffey C; Conwit RA; Lungu C; Anderson KE; Hersch SM; Ecklund DJ; Damiano EM; Itzkowitz DE; Lu S; Chase MK; Shefner JM; McGarry A; Thornell B; Gladden C; Costigan M; O'Suilleabhain P; Marshall FJ; Chesire AM; Deritis P; Adams JL; Hedera P; Lowen K; Rosas HD; Hiller AL; Quinn J; Keith K; Duker AP; Gruenwald C; Molloy A; Jacob C; Factor S; Sperin E; Bega D; Brown ZR; Seeberger LC; Sung VW; Benge M; Kostyk SK; Daley AM; Perlman S; Suski V; Conlon P; Barrett MJ; Lowenhaupt S; Quigg M; Perlmutter JS; Wright BA; Most E; Schwartz GJ; Lamb J; Chuang RS; Singer C; Marder K; Moran JA; Singleton JR; Zorn M; Wall PV; Dubinsky RM; Gray C; Drazinic C
    J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33207828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Course of irritability, depression and apathy in Huntington's disease in relation to motor symptoms during a two-year follow-up period.
    van Duijn E; Reedeker N; Giltay EJ; Eindhoven D; Roos RA; van der Mast RC
    Neurodegener Dis; 2014; 13(1):9-16. PubMed ID: 23948661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychiatry and White Matter Microstructure in Huntington's Disease.
    Gregory S; Scahill RI; Seunarine KK; Stopford C; Zhang H; Zhang J; Orth M; Durr A; Roos RA; Langbehn DR; Long JD; Johnson H; Rees G; Tabrizi SJ; Craufurd D;
    J Huntingtons Dis; 2015; 4(3):239-49. PubMed ID: 26443926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor analysis of the hospital anxiety and depression scale among a Huntington's disease population.
    Dale M; Maltby J; Martucci R; Shimozaki S;
    Mov Disord; 2015 Dec; 30(14):1954-60. PubMed ID: 26443751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical assessment of irritability, aggression, and apathy in Huntington and Alzheimer disease.
    Burns A; Folstein S; Brandt J; Folstein M
    J Nerv Ment Dis; 1990 Jan; 178(1):20-6. PubMed ID: 2136908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimising mobility outcome measures in Huntington's disease.
    Busse M; Quinn L; Khalil H; McEwan K
    J Huntingtons Dis; 2014; 3(2):175-88. PubMed ID: 25062860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An item response analysis of the motor and behavioral subscales of the unified Huntington's disease rating scale in huntington disease gene expansion carriers.
    Vaccarino AL; Anderson K; Borowsky B; Duff K; Giuliano J; Guttman M; Ho AK; Orth M; Paulsen JS; Sills T; van Kammen DP; Evans KR;
    Mov Disord; 2011 Apr; 26(5):877-84. PubMed ID: 21370269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.